Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering the next generation of biotech leaders, today announced its new German chapter. Nucleate Germany is an Associate Chapter that serves as the introduction to Nucleate and broadens access to biotech translation education in the country.
“We’re excited to work with world-class scientific institutions in Germany. It’s been an honor to work together with their academic trainees to build a stronger, globally-connected biotech community,” said Michael Retchin, Nucleate’s EVP of Strategy and a PhD candidate at Memorial Sloan Kettering Cancer Center.
Nucleate Germany will launch community-building and educational initiatives, including conferences, speaker panels, mentorship programs, and other networking events. The student-leaders of the chapter hail from Max Delbrück Center, Charité — Universitätsmedizin Berlin and Berlin Institute of Health, Technische Universität München, University of Heidelberg, European Molecular Biology Laboratory (EMBL), German Cancer Research Center (DKFZ), and other renowned institutions. They will work to strengthen the local biotech ecosystem and connect with the global biotech community, alongside other academic trainees, senior faculty, investors, founders, and other stakeholders.
“While many academic institutions now build incubator structures and optimize their processes, entrepreneurial mindset remains a key challenge. The bottom-up approach from Nucleate appears to be an intuitive answer to this burning question. It empowers PhDs and early postdocs towards building the next generation of biotech leaders,” said Georg Duda, Chair for Engineering Regenerative Therapies at Berlin Institute of Health at Charité, Berlin.
Chapter members in Munich indicated, “We are eager to unlock the potential of Germany’s excellent research output by fostering the translation of research into meaningful products through Nucleate’s unique and international biotech community.”
“Nucleate equips future visionary leaders who are paving a path for scientific entrepreneurship, with exceptional tools to make a huge impact,” added Gizem Altun, a Master’s student at DKFZ in Heidelberg.
Associate Chapters will advance in subsequent years to Core chapter designation. They will then begin running all of Nucleate’s programs, including the regional Activator program, the free and rigorous curriculum for life science venture formation. Nucleate Germany joins the Associate Chapters cohort including Argentina, Israel, Italy, and Japan.
“Nucleate Israel is excited to welcome our friends in Germany as an Associate Chapter, bringing new perspectives and collaborations with next-generation biotech leaders,” said Sarit Feldman, Master’s student at Bar-Ilan University and co-managing director of Nucleate Israel.
Nucleate’s operations are made possible by support from premier advisors, partners, and sponsors. Reach out to email@example.com to get involved.
Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders, with chapters spanning 23 regions and participation from over 120 academic institutions. Nucleate identifies future biotech entrepreneurs, removes barriers, and helps founders concentrate on building transformational technologies.
Nucleate’s programs are made possible thanks to our generous sponsors: (platinum) Alnylam, Genentech, Pillar; (gold) Alexandria LaunchLabs, Benchling, Emerald Cloud Labs, Morrison & Foerster; (silver) Latch Bio, Watershed; and philanthropic support from Schmidt Futures. Visit www.nucleate.xyz for our regional sponsors and more information.